Cannabis Bioscience International Holdings (CBIH) Financial Statements
Cannabis Bioscience International Holdings Financial Overview
Cannabis Bioscience International Holdings's market cap is currently $2.44M. The company's EPS TTM is $-0.03; its P/E ratio is -0.00; Cannabis Bioscience International Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| May 25 | May 24 | May 23 | May 22 | May 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 303.02K | $ 248.84K | $ 316.82K | $ 214.98K | $ 761.74K |
| Gross Profit | $ 262.92K | $ 203.24K | $ 223.38K | $ 168.22K | $ 758.09K |
| Operating Income | $ -421.37K | $ -486.14K | $ -983.37K | $ -888.06K | $ -114.96K |
| EBITDA | $ -335.53K | $ -497.14K | $ -905.23K | $ -834.13K | $ -111.32K |
| Net Income | $ -548.82K | $ -651.35K | $ -1.03M | $ -885.17K | $ -159.31K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.95K | $ 755.00 | $ 8.91K | $ 31.98K | $ 41.32K |
| Total Assets | $ 31.88K | $ 57.16K | $ 43.38K | $ 109.89K | $ 148.79K |
| Total Debt | $ 420.23K | $ 436.87K | $ 389.93K | $ 386.90K | $ 422.81K |
| Net Debt | $ 407.28K | $ 436.12K | $ 381.02K | $ 354.92K | $ 381.48K |
| Total Liabilities | $ 1.20M | $ 1.14M | $ 635.05K | $ 470.94K | $ 449.96K |
| Stockholders' Equity | $ -1.16M | $ -1.08M | $ -591.66K | $ -361.05K | $ -301.17K |
| Cash Flow | |||||
| Free Cash Flow | $ -329.63K | $ -479.38K | $ -913.16K | $ -855.70K | $ -507.70K |
| Operating Cash Flow | $ -329.63K | $ -479.38K | $ -913.16K | $ -855.70K | $ -507.70K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 341.82K | $ 471.22K | $ 890.09K | $ 846.36K | $ 421.37K |
Currency in USD